Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Telaprevir in Patients Undergoing Liver Transplantation for Hepatitis C
This study is currently recruiting participants.
Verified May 2013 by MassBiologics
Sponsor:
MassBiologics
Information provided by (Responsible Party):
MassBiologics
ClinicalTrials.gov Identifier:
NCT01532908
First received: February 10, 2012
Last updated: May 7, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |